Pulsenmore wins FDA nod for at-home prenatal ultrasound
November 3, 2025
Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.
Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.